By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics today said that the corporate compliance staff of the New York Stock Exchange Amex has granted the firm an extension to meet the exchange's continued listing standards.

The Waltham, Mass.-based genetic test maker will remain listed on the NYSE Amex up to June 23, subject to periodic review by the exchange staff of the firm's progress toward regaining compliance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.